The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani)

Tumori

Volumn 100, Issue 6, 2014, Pages e214-e229

  Franco, Pierfrancesco ^a   De Bari, Berardino ^b   Ciammella, Patrizia ^c   Fiorentino, Alba ^d   Chiesa, Silvia ^e   Amelio, Dante ^f   Pinzi, Valentina ^g   Bonomo, Pierluigi ^h   Vagge, Stefano ⁱ   Fiore, Michele ^j   Comito, Tiziana ^k   Cecconi, Agnese ^l   Mortellaro, Gianluca ^m   Bruni, Alessio ⁿ   Trovo, Marco ^o   Filippi, Andrea Riccardo ^a   Greto, Daniela ^h   Alongi, Filippo ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f Trento Hospital   (Italy)

^g DEPARTMENT OF NEUROSURGERY   (Italy)

^h CAREGGI UNIVERSITY HOSPITAL   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^k HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^l EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^m Gastroenterology Unit   (Italy)

ⁿ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^o CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

more..

Author keywords

Hypofractionation; Image guide radiotherapy; Intensity modulated radiotherapy; Radiosurgery; Stereotactic ablative radiotherapy; Stereotactic body radiotherapy

Indexed keywords

TEMOZOLOMIDE;

ACOUSTIC NEURINOMA; ARTICLE; BENIGN MENINGIOMA; BENIGN TUMOR; BONE METASTASIS; BRAIN DAMAGE; BRAIN METASTASIS; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; EXTERNAL BEAM RADIOTHERAPY; FRACTIONATED STEREOTACTIC RADIOTHERAPY; FUNCTIONAL DISEASE; GLIOMA; HUMAN; IRRADIATION; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PATIENT CARE; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIATION SAFETY; RADIOTHERAPY; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC PROCEDURE; STEREOTACTIC RADIOSURGERY; THORACIC RE IRRADIATION; TREATMENT INDICATION; TRIGEMINUS NEURALGIA; WHOLE BRAIN RADIOTHERAPY; BONE NEOPLASMS; BRAIN NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODE; MALE; NEOPLASMS; PATHOLOGY; PROSTATIC NEOPLASMS; RADIOSURGERY; SECONDARY;

BONE NEOPLASMS; BRAIN NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODES; MALE; NEOPLASMS; PROSTATIC NEOPLASMS; RADIOSURGERY;

EID: 84923308841     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1778.19280     Document Type: Article

References (148)

1. Filippi AR, Alongi F, Ciammella P., De Bari B, Franco P, Livi L: A strategy for young members within national radiation oncology societies: The Italian experience (AIRO Giovani group). Rep Pract Oncol Radiother, 17: 259-261, 2012.
2. Franco P, Ciammella P, Peruzzo Cornetto A, De Bari B, Buglione M, Livi L., Alongi F, Filippi AR: The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. Med Oncol, 30: 729, 2013.
3. De Bari B., Chiesa S, Filippi A.R., Gambacorta MA, D'Emilio V, Murino P, Livi L; AIRO (Italian Association of Radiation Oncology) and the AIRO Palliative Care Group: The INTER-ROMA project - a survey among Italian radiation oncologists on their approach to the treatment of bone metastases. Tumori, 97: 177-84, 2011.
4. Alongi F, De Bari B, Franco P, Ciammella P., Chekrine T, Livi L, Jereczek-Fossa BA, Filippi AR; on behalf of AIRO Young and AIRO Prostate cancer Working Group: The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer. Radiol Med, 118: 660-678, 2013.
5. De Bari B., Alongi F, Franco P., Ciammella P, Chekrine T, Livi L., Jereczek-Fossa BA, Filippi AR; on behalf of AIRO Young and AIRO Prostate cancer Working Group: The "PROCAINA (PROstate CAncer INdication Attitudes) Project" (Part II) - A survey among Italian radiation oncologists on radical radiotherapy in prostate cancer. Radiol Med, 118: 1220-1239, 2013.
6. Ciammella P, De Bari B, Fiorentino A, Franco P., Cavuto S, Alongi F, Livi L., Filippi AR; AIRO Giovani (Italian Association of Radiation Oncology - Young Members Working Group): The 'BUONGIORNO Project': burn out syndrome among young Italian radiation oncologists. Cancer Invest, 31: 522-528, 2013.
7. De Bari B., Fiorentino A, Greto D., Ciammella P, Arcangeli S, Avuzzi B., D'Angelillo RM, Desideri I, Kirienko M., Marchiori D, Massari F, Fundoni C., Franco P, Filippi AR, Alongi F: Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting. Tumori, 99: 637-649, 2013.
8. Filippi AR, Franco P, Ricardi U: Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer? Rep Pract Oncol Radiother, 19: 275-279, 2013.
9. Alongi F, Arcangeli S, Filippi A.R., Ricardi U., Scorsetti M: Review and uses of stereotactic body radiation therapy in oligometastases. Oncologist, 17: 1100-1107, 2012.
10. Ricardi U, Filippi AR, Franco P: New concepts and insights into the role of radiation therapy in extracranial metastatic disease. Expert Rev Anticancer Ther, 13: 1145-1155, 2013.
11. Arcangeli S, Scorsetti M, Alongi F: Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A Review. Crit Rev Oncol Hematol, 84: 101-108, 2012.
12. Scorsetti M, Alongi F, Filippi A.R., Pentimalli S., Navarria P, Clerici E, Castiglioni S., Tozzi A, Reggiori G, Mancosu P., Ricardi U: Long-term local control achieved after hypofrac-tionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients. Acta Oncol, 51: 618-623, 2012.
13. Filippi AR, Badellino S, Guarneri A., Levis M, Botticella A, Mantovani C., Ragona R, Racca P, Buffoni L., Novello S, Ricardi U: Outcomes of single fraction stereotactic ablative radiotherapy in lung metastases. Technol Cancer Res Treat, 13: 37-45, 2014.
14. Alongi F, Fogliata A, Clerici E., Navarria P, Tozzi A, Comito T., Ascolese AM, Clivio A, Lobefalo F, Reggiori G., Cozzi L, Mancosu P, Tomatis S., Scorsetti M: Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients. Radiat Oncol, 7: 204, 2012.
15. Navarria P, Ascolese AM, Tomatis S, Cozzi L., De Rose F, Mancosu P, Alongi F., Clerici E, Lobefalo F, Tozzi A., Reggiori G, Fogliata A, Scorsetti M: Stereotactic body radiotherapy (SBRT) in lung oligometastatic patients: role of local treatments. Radiat Oncol, 9: 91, 2014.
16. Davis JN, Medbery C 3rd, Sharma S, Danish A, Mahadevan A: The RSSearch Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body. Radiat Oncol, 8: 275, 2013.
17. Karim AB, Maat B, Hatlevoll R., Menten J, Rutten EH, Thomas D.G., Mascarenhas F., Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini M.G., van Alphen AM, Hamers H P, Gaspar L, Noordman E., Pierart M, Glabbeke M: A randomized trial on dose response in radiation therapy of lowgrade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys, 36: 549-556, 1996.
18. Shaw E, Arusell R, Scheithauer B., O'Fallon J, O'Neill B, Dinapoli R, Nelson D., Earle J, Jones C, Cascino T., Nichols D, Ivnik R, Hellman R., Curran W, Abrams R: Prospective randomized trial of lowversus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol, 20: 2267-2276, 2002.
19. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmström P-O, Collette L, Pierart M, Mirimanoff R, Karim ABMF, for the EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council: Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet, 366: 985-990, 2005.
20. Pozza F, Colombo F, Chierego G., Avanzo RC, Marchetti C, Benedetti A, Casentini L., Danieli D: Low-grade astrocytomas: treatment with unconventionally fractionated external beam stereotactic radiation therapy. Radiology, 171: 565-569, 1989.
21. Souhami L, Olivier A, Podgorsak E.B., Villemure JG, Pla M, Sadikot AF: Fractionated stereotactic radiation therapy for intracranial tumors. Cancer, 68: 2101-2108, 1991.
22. Roberge D, Souhami L, Oliver A., leblanc R, Podgorsak E: Hypofractionated stereotactic radiotherapy for low grade glioma at McGill University: long-term follow-up. Technol Cancer Res Treat, 5: 1-8, 2006.
23. Combs SE, Ahmadi R, Schulz-Ertner D, Thilmann C., Debus J: Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation: J Neurooncol, 71: 319-323, 2005.
24. Van Kampen M., Engenhart-Cabillic R, Debus J., Hess T, Schad LR, Wannenmacher MF: Low-grade astrocytoma: treatment with conventionally fractionated stereotactic radiation therapy. Radiology 201: 275-278, 1996.
25. Stupp R, Mason W P, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide or glioblastoma. N Engl J Med, 352: 987-996, 2005.
26. Sarkaria JN, Mehta M P, Loeffler JS, Buatti J.M., Chappell RJ, Levin AB, Alexander E 3rd, Friedman WA, Kinsella TJ: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group, 32: 931-941, 1995.
27. Loeffler JS, Alexander E 3rd, Shea WM, Wen PY, Fine HA, Kooy HM, Black PM: Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol, 10: 1379-1385, 1992.
28. Shaw E, Scott C, Souhami L., Dinapoli R, Bahary J P, Kline R, Wharam M., Schultz C, Davey P, Loeffler J., Del Rowe J, Marks L, Fisher B., Shin K: Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys, 34: 647-654, 1996.
29. Souhami L1, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta M P, Curran WJ Jr: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patient with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys, 60: 853-860, 2004.
30. Cardinale R, Won M, Choucair A., Gillin M, Chakravarti A, Schultz C., Souhami L, Chen A, Pham H., Mehta M: A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys, 65: 1422-1428, 2006.
31. Combs E, Debus J, Schulz-Ertner D: Radiotherapeutic alternatives for previously irradiated recurrent gliomas. BMC Cancer, 7: 167, 2007.
32. Minniti G, Scaringi C, De Sanctis V, Lanzetta G, Falco T., Di Stefano D, Esposito V, Maurizi Enrici R: Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas. BMC Cancer, 7: 167, 2007.
33. Cuneo KC, Vredenburgh JJ, Sampson J.H., Reardon DA, Desjardins A, Peters KB, Friedman H.S., Willet CG, Kirkpatrick JP: Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys, 82: 2018-2024, 2012.
34. Cabrera AR, Cuneo KC, Desjardins A, Sampson J.H., McSherry F., Herndon JE 2nd, Peters KB, Allen K, Hoang JK, Chang Z, Craciunescu O, Vredenburgh JJ, Friedman HS, Kirkpatrick JP: Concurrent stereotactic radiosurgery and bevacizumab in recurrent gliomas: a prospective trial. Int J Radiat Oncol Biol Phys, 86: 873-879, 2013.
35. Gaspar LE, Scott C, Murray K., Curran W: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys, 47: 1001-1006, 2000.
36. Gaspar L, Scott C, Rotman M., Asbell S, Phillips T, Wasserman T., McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Oncology Group (RTOG) bain metastases trial. Int J Radiat Oncol Biol Phys, 37: 745-751, 1997.
37. Sperduto PW, Berkey B, Gaspar L.E., Mehta M., Curran W: A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys, 70: 510-514, 2008.
38. Shaw E, Scott C, Souhami L., Dinapoli R, Kline R, Loeffler J., Farnan N: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys, 47: 291-298, 2000.
39. Vogelbaum MA, Angelov L, Lee S.Y., Li L., Barnett GH, Suh JH: Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg, 104: 907-912, 2006.
40. McDermott MW and Sneed PK: Radiosurgery in metastatic brain cancer. Neurosurgery, 57: S45-53, 2005.
41. Kondziolka D, Patel A, Lunsford L.D., Kassam A., Flickinger JC: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys, 45: 427-434, 1999.
42. Andrews DW, Scott CB, Sperduto P.W., Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W., Ryu J, Bahary J P, Souhami L, Rotman M., Mehta M P, Curran WJ Jr: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet, 363: 1665-1672, 2004.
43. Aoyama H, Shirato H, tago M., Nakagawa K, Toyoda T, Hatano K., Kenjyo M, Oya N, Hirota S., Shioura H, Kunieda E, Inomata T., Hayakawa K, Katoh N, Kobashi G: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for the treatment of brain metastases: a randomized controlled trial. JAMA, 295: 2483-2491, 2006.
44. Kocher M, Soffietti R, Abacioglu U., Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP: Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol, 29: 134-141, 2011.
45. Aoyama H, Tago M, Kato N., Toyoda T, Kenjo M, Hirota S., Shioura H, Inomata T, Kunieda E., Hayakawa K, Nakagawa K, Kobashi G., Shirato H: Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys, 68: 1388-1395, 2007.
46. Chang EL, Wefel JS, Hess K.R., Allen PK, Lang F F, Kornguth DG, Arbuckle R.B., Swint JM, Shiu AS, Maor MH, Meyers CA: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomized controlled trial. Lancet Oncol, 10: 1037-1044, 2009.
47. Jairam V, Chiang VL, Yu J.B., Knisely JP: Role of stereotactic radiosurgery in patients with more than four brain metastases. CNS Oncol, 2: 1-18, 2013.
48. Tsao MN, Rades D, wirth A., Lo SS, Danielson BL, Gaspar LE, Sperduto P.W., Vogelbaum MA, Radawski JD, Wang JZ, Gillin M.T., Mohideen N., Hahn CA, Chang EL: Radiothera-peutic and surgical management for newly diagnosed brain metastasis(es): An American Society for radiation Oncology evidence-based guideline. Pract Radiat Oncol, 2: 210-225, 2012.
49. Franco P, Numico G, Migliaccio F., Catuzzo P, Cante D, Ceroni P., Sciacero P, Carassai P, Canzi P., La Porta MR, Girelli G, Borca VC, Pasquino M, Tofani S., Ozzello F, Ricardi U: Head and neck region consolidation radiotherapy and prophylactic cranial irradiation with hippocampal avoidance delivered with helical tomotherapy after induction chemotherapy for non-sinonasal neuroendocrine carcinoma of the upper airways. Radiat Oncol, 7: 21, 2012.
50. Gondi V, Tome WA, Mehta MP: Why avoid the hippocampus? A comprehensive review. Radiother Oncol, 97: 370-376, 2010.
51. Nedzi LA: The implementation of ablative hypofractionated radiotherapy for stereotactic treatments in the brain and body: observations on efficacy and toxicity in clinical practice. Sem Radiat Oncol, 18: 265-272, 2008.
52. Kondziolka D, Mathieu D, Lunsford L.D., Martin JJ, Madhok R, Niranjan A, Flickinger JC: Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery, 62: 53-58, 2008.
53. Bloch O, Kaur G, Jian B.J., Parsa AT, Barani IJ: Stereotactic radiosurgery for benign meningiomas. J Neurooncol, 107: 13-20, 2012.
54. Pollock BE, Stafford SL, Link M.J., Garces YI, Foote RL: Single-fraction radiosurgery for presumed intracranial meningiomas: efficacy and complications for a 22-year experience. Int J Radiat Oncol Biol Phys, 83: 1414-1418, 2012.
55. Skeje BS, Enger PO, Skeie G.O., Thorsen F., Pdersen PH. Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. Neurosurgery, 66: 661-668, 2010.
56. Pollock BE, Stafford SL, Link M.J., Brown PD, Garces YI, Foote RL: Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery, 71: 604-613, 2012.
57. Kim YH1, Kim DG, Han JH, Chung HT, Kim IK, Song SW, Park JH, Kim JW, Kim YH, Park CK, Kim CY, Paek SH, Jung HW: Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion. Int J Radiat Oncol Biol Phys, 85: 61-67, 2013.
58. Collen C, Ampe B, Gevaert T., Moens M, Linthout N, de Ridder M, Verellen D, D'Haens J, Storme G: Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys, 81: e503-e509, 2011.
59. Hasegawa T, Kida Y, Kato T., Iizuka H, Yamamoto T: Factors associated with hearing preservation after Gamma Knife for vestibular schwannomas in patients who retain serviceable hearing: clinical article. J Neurosurg, 115: 1078-1086, 2011.
60. Kondziolka D: Functional radiosurgery. Neurosurgery, 44: 12-20, 1999.
61. Kondziolka D, Lunsford LD, Flickinger J.C., Young R F, Vermeulen S, Duma C.M., Jacques DB, Rand RW, Regis J, Peragut J.C., Manera L., Epstein MH, Lindquist C: Stereotactic radiosurgery for trigeminal neuralgia: a multi-institutional study using gamma unit. J Neurosurg, 84: 940-945, 1996.
62. Marshall K, Chan MD, McCoy T P, Aubuchon AC, Bourland J.D., McMullen K P, deGuzman A F, Munley MT, Shaw E.G., Tatter SB, Ellis TL: Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife radiosurgery. Neurosurgery, 70: 566-573, 2012.
63. Massager N, Lorenzoni J, Devriendt D., Devriendt D, Desmedt F, Brotchi J., Levrier M: Gamma knife surgery for idiopathic trigeminal neuralgia performed using a faranterior cisternal target and a high dose of radiation. J Neurosurg, 100: 597-605, 2004.
64. Regis J, Metellus P, Hayashi M., Roussel P, Donnet A, Bille-Turc F: Prospective controlled trial of gamma knife surgery for essential trigeminal neuralgia. J Neurosurg, 104: 913-924, 2006.
65. Kondziolka D, Zoro O, Lobato-Polo J, Kano H., Flannery TJ, Flickinger JC, Lunsford LD: Gamma Knife stereotactic radiosurgery for idiopathic trigeminal neuralgia. J Neurosurg, 112: 758-765, 2010.
66. Koller WC, Lyons KE, Wilkinson S.B., Troster AL, Pahwa R: Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord, 16: 464-468, 2001.
67. Kondziolka D, Ong JG, Lee J.Y., Moore RY, Flickinger JC, Lunsford LD: Gamma Knife thalamotomy for essential tremor. J Neurosurg, 108: 111-117, 2008.
68. Duman CM, Jacques DB, Kopyov OV: Gamma Knife radiosurgery of thalamotomy in parkinsonian tremor: five years of experience. J Neurosurg, 88: 1044-1049, 1998.
69. Detterbeck FC, Gibson CJ: Turning gray: the natural history of lung cancer over time. J Thorac Oncol, 3: 781-789, 2008.
70. Palma D, Visser O, Lagerwaard F.J., Belderbos J., Slotman BJ, Senan S: Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small cell lung cancer: a population-based time-trend analysis. J Clin Oncol, 28: 5153-5159, 2010.
71. Grutters J.P., Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P: Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol, 95: 32-40, 2010.
72. Fakiris AJ, McGarry RC, Yiannoutsos C.T., Papiez L., Williams M, Henderson MA, Timmerman R: Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys, 75: 677-682, 2009.
73. Ricardi U, Filippi AR, Guarneri A, Giglioli F.R., Ciammella P., Franco P, Mantovani C, Borasio P., Scagliotti G V, Ricardi U: Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer, 68: 72-77, 2010.
74. Soldà F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M: Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol, 109: 1-7, 2013.
75. Ricardi U, Frezza G, Filippi A.R., Badellino S., Levis M, Navarria P, Salvi F., Marcenaro M, Trovo M, Guarneri A, Corvo R, Scorsetti M: Stereotactic ablative radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study. Lung Cancer, 84: 248-253, 2014.
76. Timmerman R, McGarry R, Yiannoutsos C., Papiez L, Tudor K, DeLuca J., Ewing M, Abdulrahman R, DesRosiers C., Williams M, Fletcher J: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol, 24: 4833-4839, 2006.
77. Haasbeek CJ, Lagerwaard FJ, Slotman B.J., Senan S: Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol, 6: 2036-2043, 2011.
78. Senthi S, Haasbeek CJ, Slotman B, Senan S: Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. Radiother Oncol, 106: 276-282, 2013.
79. Lo SS, Moffat-Bruce S, Dawson L.A., Schwarz RE, Teh BS, Mayr NA, Lu J.J., Grecula JC, Olencky TE, Timmerman RD: The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol, 8: 405-416, 2011.
80. The International Registry of Lung Metastases: Long-term results of lung metastasectomy prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg, 113: 37-49, 1997.
81. Chmura SJ, Salama JK, Weichselbaum RR: Stereotactic radiotherapy for pulmonary metastases. Semin Thorac Cardiovasc Surg, 25: 292-299, 2013.
82. Peulen H, Karlsson K, Lindberg K., Tullgren O, Baumann P, Lax I., Lewensohn R, Wersall P: Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiother Oncol, 101: 260-266, 2011.
83. Liu H, Zhang X, Vinogradskiy Y.Y., Swisher SG, Komaki R, Chang JY: Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys, 84: 1017-1023, 2012.
84. Trakul N, Harris J P, Le QT, Hara W.Y., Maxim PG, Loo BW Jr, Diehn M: Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol, 7: 1462-1465, 2012.
85. Meijneke TR, Petit S F, Pentzler D, Hoogeman M., Nuyttens JJ: Reirradiation and stereotactic radiotherapy for tumors in the lung: Dose summation and toxicity. Radiother Oncol, 107: 423-427, 2013.
86. Reyngold M, Wu AJ, McLane A, Zhang Z., Hsu M, Stein N F, Zhou Y, Ho A.Y., Rosenzweig KE, Yorke ED, Rimner A: Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiat Oncol, 8: 99, 2013.
87. Kilburn JM, Kuremsky JG, Blackstock A.W., Munley MT, Kearns WT, Hinson WH, Lovato J F, Miller AA, Petty W.J., Urbanic JJ: Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol, 110: 505-510, 2014.
88. Trovò M, Minatel E, Durofil E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG: Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 88: 1114-1119, 2014.
89. Scheele J, Stangl R, Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg, 77: 1241-1246, 1990.
90. Cunningham D, Pyrhonen S, James R.D., Punt CJ, Hickish T F, Heikkila R, Johannesen T.B., Starkhammar H., Topham CA, Awad L, Jaques C, Herait P: Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet, 352: 1413-1418, 1998.
91. Van Ruth S., Mutsaerts E, Zoetmulder F.A., van Coevorden F: Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol, 27: 662-667, 2001.
92. Adam R, De Gramont A, Figueras J, Guthrie A., Kokudo N, Kunstlinger F, Loyer E., Poston G, Rougier P, Rubbia-Brandt L, Sobrero A., Tabernero J, The C, Van Cutsem E; Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of Liver Metastases): The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist, 17: 1225-1239, 2012.
93. Gillams AR, Lees WR: Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol, 19: 1206-1213, 2009.
94. De Bari B., Guillet M, Mornex F: Stereotactic body radiation therapy (SBRT) in the treatment of liver metastases: state of the art. Cancer Radiother, 15: 72-76, 2011.
95. De Bari B., Pointreau Y, Rio E., Miralbel X, Mornex F: Normal tissue tolerance to external beam radiation therapy: liver. Cancer Radiother, 14: 344-349, 2010.
96. Blomgren H, Lax I, Naslund I., Svanstrom R: Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol, 34: 861-870, 1995
97. Katz AW, Carey-Sampson M, Muhs A.G., Milano MT, Schell MC, Okunieff P: Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys, 67: 793-798, 2007.
98. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber V.W., Burri SH, Feigenberg SJ, Chidel MA, Pugh T.J., Franklin W., Kane M, Gaspar LE, Schefter TE: Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol, 27: 1572-1578, 2009.
99. Scorsetti M, Arcangeli S, Tozzi A., Comito T, Alongi F, Navarria P., Mancosu P, Reggiori G, Fogliata A., Torzilli G, Tomatis S, Cozzi L: Is stereotactic body radiation therapy an attractive option for unresectable liver metastasis? A preliminary report form a phase 2 trial. Int J Radiat Oncol Biol Phys, 86: 336-342, 2013.
100. Chang DT, Swaminath A, Kozak M., Weintraub J, Koong AC, Kim J, Dinniwell R., Brierley J, Kavanagh BD, Dawson L.A., Schfter TE: Stereotactic body radiotherapy for colo-rectal liver metastases: a pooled analysis. Cancer, 117: 4060-4069, 2011.
101. Scorsetti M, Clerici E, Comito T: Stereotactic body radiotherapy for liver metastases. J Gastrointest Oncol, 5: 190-197, 2014.
102. Mirabell R, Roberts SA, Zubizzareta E, Hendry JH: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5.969 patients in seven international institutional datasets: α/β =1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys, 82: e17-e24, 2012.
103. Welz S, Nyazi M, Belka C., Ganswindt U: Surgery vs. radiotherapy in localized prostate cancer. Which is best? Radiat Oncol 3: 23, 2008.
104. Katz AJ, Santoro M, Dibiasio F., Ashley R: Stereotactic body radiation therapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat Oncol, 8: 118, 2013.
105. Alongi F, Cozzi L, Arcangeli S., Iftide C, Comito T, Villa E., Lobefalo F, Navarria P, reggiori G., Mancosu P, Clerici E, Fogliata E., Tomatis S, Taverna G, Graziotti P., Scorsetti M: Linac-based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study. Radiat Oncol, 8: 171, 2013.
106. King CR, Freeman D, Kaplan I., Fuller D, Bolzicco G, Collins S., Meier R, Wang J, Kupelian P., Steinberg M, Katz A: Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol, 109: 217-221, 2013.
107. Yu JB, Cramer LD, Herrin J, Soulos P.R., Potosky AL, Gross CP: Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity. J Clin Oncol, 32: 1195-1201, 2014.
108. Arcangeli S, De Bari B, Alongi F: In reply to Yu et al. J Clin Oncol, 32(30): 3454, 2014.
109. Gunnlaugsson A, Kjellen E, Hagberg O., Thellenberg-Karlsson C, Widmark A, Nilsson P: Change in prostate volume during extreme hypo-fractionation analysed with MRI. Radiat Oncol, 9: 22, 2014.
110. De Bari B., Alongi F, Buglione M., Campostrini F, Briganti A, Berardi G., Petralia G, Bellomi M, Chiti A., Fodor A, Suardi N, Cozzarini C., Nadia DM, Scorsetti M, Orecchia R, Montorsi F., Bertoni F, Magrini SM, Jereczeck-Fossa BA: Salvage therapy of small volume prostate cancer nodal failure: a review of the literature. Crit Rev Oncol/Hematol, 90: 24-35, 2014.
111. Higginson DS, Morris DE, Jones E.L., Clarke-Pearson D, Varia MA: Stereotactic body radiotherapy (SBRT): technological innovation and application in gynecologic cancer. Gynecol Oncol, 120: 404-412, 2011.
112. De Bari B., Alongi F, Lestrade L., Giammarile F: Choline-PET in prostate cancer management: the point of view of the radiation oncologist. Crit Rev Oncol Hematol, 91: 234-237, 2014.
113. Berkovic P, De Meerleer G, Delrue L, Lambert B., Fonteyne V, Lumen N, Decaestecker K., Villeirs G, Vuye P, Ost P: Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy. Clin Genitourin Cancer, 11: 27-32, 2013.
114. Long B, Eskander RN, Tewari KS: Use of stereotactic radiosurgery in the treatment of gynecologic malignancies: A review. World J Radiol, 6: 366-373, 2014.
115. Choi CW, Cho CK, Yoo, SY, Kim M.S., Yang KM, Yoo HJ, Seo YS, Kang J.K., Lee DH, Lee KH, Lee ED, Rhu S.Y., Choi SC, Kim MH, Kim BJ: Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases form uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys, 74: 147-153, 2009.
116. Wong DA, Fornasier VL, MacNab I: Spinal metastases: the obvious, the occult, and the impostors. Spine, 15: 1-4, 1990.
117. Jacobson A.F., Shapiro CL, Van den Abbeele AD, Kaplan WD: Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma. Cancer, 91: 17-24, 2001.
118. Lutz S, Berk L, Chang E., Chow E, Hanh C, Hoskin P., Howell D, Konski A, Kachnic L., Lo S, Sahgal A, Silverman L., von Gunten C, Mendel E, Vassil A., Bruner D, Hartsell W: Palliative radiotherapy for bone metastases: an ASTRO evidence based guideline. Int J Radiat Oncol Biol Phys, 79: 965-976, 2011.
119. Nguyen QN, Shiu AS, Rhines L.D., Wang H., Allen PK, Wang XS, Chang EL: Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys, 76: 1185-1192, 2010.
120. Greco C, Zelefsky MJ, Lovelock M, Fuks Z., Hunt M, Rosenzweig K, Zatcky J., Kim B, Yamada Y: Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys, 79: 1151-1157, 2011.
121. Zelefsky MJ, Greco C, Motzer R., Magsanoc JM, Pei X, Lovelock M, Mechalakos J., Zatcky J, Fuks Z, Yamada Y: Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys, 82: 1744-1748, 2012.
122. Cunha MV, Al-Omair A, Atenafu E.G., Masucci GL, Letourneau D, Korol R, Yu E., Howard P, Lochray F, da Costa LB, Fehlings MG, Sahgal A: Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors. Int J Radiat Oncol Biol Phys, 84: e343-349, 2012.
123. Kirkpatrick J.P., van der Kogel AJ, Schultheiss TE: Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys, 76: S42-S49, 2010.
124. Corvo R, Lamanna G, Vagge S, Belgioia L, Bosetti D, Aloi D, Timon G, Bacigalupo A: Once-weekly stereotactic radiotherapy for patients with oligometatses: compliance and preliminary efficacy. Tumori, 99: 159-163, 2013.
125. Bonomo P, Cipressi S, Iermano C., Bonucci I, Masi L, Doro R., Favuzza V, Paiar F, Simontacchi G., Meattini I, Greto D, Agresti B., Livi L, Biti G: Salvage stereotactic re-irradiation with Cyberknife for locally recurrent head and neck cancer: a single center experience. Tumori, 100: 278-283, 2014.
126. Bonomo P, Cipressi S, Saieva C., Greto D, Masi L, Paiar F., Di Cataldo V, Meattini I, Cecchini S., Magoni M, Doro R, Iermano C., Bonucci I, Livi L, Biti G: Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. Tumori, 99: 611-616, 2013.
127. Rosen LR, Fischer-Valuck BW, Katz S.R., Durci M., Wu HT, Syh J, Syh J, Patel B: Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center. Tumori, 100: 42-48, 2014.
128. Unger KR, Lominska CE, Chanyasulkit J, Randolph-Jackson P, White R.L., Aulisi E., Jacobson J, Jean W, Gagnon GJ: Risk factors for posttreatment edema in patients treated with stereotactic radiosurgery for meningiomas. Neurosurgery, 70: 639-645, 2012.
129. Santacroce A, Walier M, Regis J., Liscak R, Motti E, Lindquist C., Kemeny A, Kitz K, Lippitz B., Martinez Alvarez R, Pedersen PH, Yomo S, Lupidi F., Dominikus K, Blackburn P, Mindermann T., Bundschuh O, van Eck AT, Fimmers R, Horstmann GA: Long-term tumor control of benign in-tracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery, 70: 32-39, 2012.
130. Kopp C, Fauser C, Muller A., Astner ST, Jacob V, Lumenta C, Meyer B., Tonn JC, Molls M, Grosu AL: Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about stereotactic methods form a single institution. Int J Radiat Oncol Biol Phys, 80: 1485-1491, 2011.
131. Nagata Y, Takayama K, Matsuo Y., Norisha Y, Mizowaki T, Sakamoto T., Sakamoto M, Mitsumori M, Shibuya K., Araki N, Yano S, Hiraoka M: Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys, 63: 1427-1431, 2005.
132. Baumann P, Nyman J, Hoyer M., Wennberg B, Gagliardi G, Lax I., Drugge N, Ekberg L, Friesland S., Johansson KA, Lund JA, Morhed E, Nilsson K., Levin N, Paludan M, Sederholm C., Traberg A, Wittgren L, Lewensohn: Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol, 27: 3290-3296, 2009.
133. Timmerman R, Paulus R, Galvin J., Michalski J, Straube W, Bradley J., Fakiris A, Bezjak A, Videtic G., Johnstone D, Fowler J, Gore E., Choy H: Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA, 303: 1070-1076, 2010.
134. Takeda A, Kunieda E, Ohashi T., Aoky Y, Koike N, Takeda T: Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancer in comparison with primary lung cancer. Radiother Oncol, 101, 255-259, 2011.
135. Ricardi U, Filippi AR, Guarneri A, Ragona R., Mantovani C, Giglioli F, Botticella A., Ciammella P, Iftode C, Buffoni L., Ruffini E, Scagliotti GV: Stereotactic body radiation therapy for lung metastases. Lung Cancer, 75: 77-81, 2012.
136. Norihisa Y, Nagata Y, Takayama K., Matsuo Y, Sakamoto T, Mizowaki T., Yano S, Hiraoka M: Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys, 72, 398-403, 2008.
137. Rusthoven KE, Kavanagh BD, Burri S.H., Chen C., Cardenes H, Chidel MA, Pugh T.J., Kane M., Gasper LE, Shefter TE: Multi institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol, 27: 1579-1584, 2009.
138. Hoyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J., Nellemann H, Kiil Berthelsen A, Grau C, Aage Engelholm S, Von der Maase H: Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol, 45: 823-830, 2006.
139. Mendez Romero A., Wunderink W, Hussain S.M., De Pooter JA, Heijmen BJ, Nowak PC, Nuyttens JJ, Brandwijk R P, Verhoef C, Ijzermans J.N., Levendag PC: Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol, 45: 831-837, 2006.
140. Lee MT, Kim JJ, Dinniwell R, Brierley J., Lockwood G, Wong R, Cummings B., Ringash J, Tse RV, Knox J.J., Dawson LA: Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol, 27: 1585-1591, 2009.
141. Bolzicco G, Favretto MS, Satariano N, Scremin E., Tambone C, Tasca A: A Single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy. BMC Urol, 13: 49, 2013.
142. Chen LN, Suy S, Uhm S., Oermann EK, Ju AW, Chen V, Hanscom H.N., Laing S., Kim JS, Lei S, Batipps G P, Kowalczyk K, Bandi G., Pahira J, McGeagh KG, Collins B.T., Krinshnan P., Dawson NA, Taylor KL, Dritschilo A, Lynch J.H., Collins SP: Stereotactic body radiotherapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Radiat Oncol, 8: 58, 2013.
143. Choi CW, Cho CK, Yoo S.Y., Kim MS, Yoo HJ, Seo YS, Kang J.K., Lee DH, Lee KH, Lee ED, Rhu S.Y., Choi SC, Kim MH, Kim BJ: Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys, 74: 147-153, 2009.
144. Jereczek-Fossa B.A., Fariselli L, Beltramo G., Catalano G, Serafini F, Garibaldi C., cambria R, Brait L, Possanzini M., Bianchi LC, Vavassori A, Zerini D, Orsi F., de Cobelli O, Orecchia R: Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer. Radiother Oncol, 93: 14-17, 2009.
145. Kim MS, Yoo SY, Cho C.K., Yoo HJ, Kang JK, Lee DH, Lee J.I., Bang HY, Kim MS, Kang HJ: Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer. J Korean Med Sci, 24: 488-492, 2009.
146. Kim MS, Cho CK, Yang K.M., Lee DH, Moon SM, Shin YJ: Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence form colorectal cancer. World J Gastroenterol, 15: 6091-6095, 2009.
147. Bignardi, Navarria P, Mancosu P, Cozzi L, Fogliata A, Tozzi A, Castiglioni S, Carnaghi C, Tronconi MC, Santoro A, Scorsetti M: Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Int J Radiat Oncol Biol Phys, 81: 831-838, 2011.
148. Sahgal A, Atenafu EG, Chao S, Al-Omair A, Boehling N., Balagamwala EH, Cunha M, Thibault I, Angelov L., Borwn P, Suh J, Rhines L.D., Fehlings MG, Chang E: Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol, 31: 3426-3431, 2013.